1-5 of 5
Mark Wunderlich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fusion-specific chromatin profiles mediate transcriptional heterogeneity in MLL-rearranged acute lymphoblastic leukemia

Shan Lin, Michael Kotliar, Sushmitha Vallabh, Anetta Ptasinska, Salam a Assi, Mark Wunderlich, Constanze Bonifer, Artem Barski, James C Mulloy
Journal: Blood Advances
Blood Adv bloodadvances.2024014065.
https://doi.org/10.1182/bloodadvances.2024014065
Published: 2024
Includes: Supplemental data
Journal Articles

Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development

Sarai T. Dean, Chiharu Ishikawa, Xiaoqin Zhu, Sean Walulik, Timothy Nixon, Jessica K. Jordan, Samantha Henderson, Michael Wyder, Nathan Salomonis, Mark Wunderlich, Kenneth D. Greis, Daniel T. Starczynowski, Andrew G. Volk
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4822–4837.
https://doi.org/10.1182/bloodadvances.2022009438
Published: 2023
Includes: Supplemental data
Journal Articles

Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML

Mohammad Azhar, Zachary Kincaid, Meenu Kesarwani, Jacob Menke, Joshua Schwieterman, Sekhu Ansari, Angela Reaves, Arhama Ahmed, Rammsha Shehzad, Areeba Khan, Nuha Syed, Noor Amir, Mark Wunderlich, Tahir Latif, William Seibel, Mohammad Azam
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1460–1476.
https://doi.org/10.1182/bloodadvances.2022007486
Published: 2023
Includes: Supplemental data
Journal Articles

Momelotinib is a highly potent inhibitor of FLT3-mutant AML

Mohammad Azhar, Zachary Kincaid, Meenu Kesarwani, Arhama Ahmed, Mark Wunderlich, Tahir Latif, Daniel Starczynowski, Mohammad Azam
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1186–1192.
https://doi.org/10.1182/bloodadvances.2021004611
Published: 2022
Includes: Supplemental data
Journal Articles

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy

Lynn H. Lee, Christa Krupski, Jason Clark, Mark Wunderlich, Robert B. Lorsbach, Michael S. Grimley, Matthew Burwinkel, Adam Nelson, Ashish R. Kumar
Journal: Blood Advances
Blood Adv (2020) 4 (4): 717–727.
https://doi.org/10.1182/bloodadvances.2019032367
Published: 2020
Includes: Supplemental data